01638nas a2200361   4500000000100000008004100001260001600042653002600058653001600084653002000100653002300120653001100143653001100154653003700165653001200202653001300214653002100227653002300248653002900271653001400300653004000314653002000354653001700374100001300391700001600404700001500420700002100435245009100456300001100547490000800558520069600566022001401262       1975                            d  c1975 Mar 2810aArthritis, Rheumatoid10aCandidiasis10aChronic Disease10aCoccidioidomycosis10aFemale10aHumans10aImmunologic Deficiency Syndromes10aleprosy10aMelanoma10aMolecular Weight10aMultiple Sclerosis10aMycobacterium Infections10aNeoplasms10aSubacute Sclerosing Panencephalitis10aTransfer Factor10aTuberculosis1 aGrob P J1 aReymond J F1 aHäcki M A1 aFrey-Wettstein M00a[Transfer factor. Properties and possible therapeutic applications (author's transl)].  a517-240 v1173 a<p>Transfer factor (TF) is a dialysable and ultrafilterable extract from human leukocytes. It contains only substances with a molecular weight of less than 10 000. Several biological activities of TF are so far known. These refer to the transfer of specific cellular immunity from one individual to another and a stimulating effect, probably of an unspecific nature, on the cellular immune system. So far, favorable therapeutic results have been obtained in chronic candidiasis and a few other chronic infectious diseases, in the Wiskott-Aldrich syndrome and possibly also in some special malignant tumors. The small number of treatments does not permit any firm conclusions to be drawn.</p>  a0341-3098